MOTS-c 2-3x weekly (intermittent) or low-dose daily
Patient-specific factors Choice of GLP-1 medication also depends on certain factors like the presence of renal or hepatic issues, history of severe gastrointestinal side effects (gallstones, severe stomach pain, and pancreatitis), blood sugar levels, and weight loss goals
Stay full for hours
However, for patients with chronic kidney disease (CKD) , these medications require careful dosing to avoid risks like dehydration, electrolyte imbalances, and acute kidney injury
[email protected] [email protected] +86-21-61941042 86-216-194-1042 CONTACT US Products Antibodies Epitope Tag Antibodies Loading Control Antibodies Catalog Antibodies Payload Antibodies Catalog Peptides Amyloid peptides Antimicrobial Peptides Neuropeptides RGD Peptides Catalog Peptides Recombinant Proteins Cytokines Immune Checkpoint Biomarker Enzymes & Kinase Catalog Proteins Services Protein Service Protein Crystallography E.coli Expression System Mammalian Cell Expression Peptide Synthesis Custom peptide Synthesis Glycopeptide Synthesis Peptide Library Service Isotope Labeled Peptides Radiolabeled Peptides Molecular Biology Gene Synthesis Site-Directed Mutagenesis Plasmid DNA Preparation Custom DNA Oligos Modifications RNA Chemical Synthesis Resources & Support FAQs News Highlights Vector Maps NovoBuilder Online Tools Company About us Contact Cart 2 All All Antibodies Proteins Peptides Vectors Featured Products Exatecan Monoclonal Antibody Description Anti-Exatecan mAb Application ELISA Eribulin Monoclonal Antibody Description Anti-Eribulin mAb Application ELISA Anti-FMC63 antibody Description Antibody against FMC63 scFv Application Evaluation of Anti-CD19 (FMC63 scFv) CAR Expression DT3C protein Description Diphtheria toxin & spg 3C domain Application Evaluating antibody internalization Products Center Antibodies Payload Antibody Primary Antibody View More Proteins Cytokines Enzymes View More Peptides Antimicrobial Peptides Amyloid Peptides View More Plasmids View More New Arrivals Latest Recombinant SPC25 protein (His tag) Recombinant TM204 protein (His tag) Recombinant NPS3B protein (His tag) Recombinant SMD3 protein (His tag) Recombinant MDM2 protein (His tag) Antifreeze peptide SS-3 Recombinant ZC12A protein (His tag) Human BRD7 Recombinant protein (GST tag & His tag) Recombinant MED11 protein (His tag) Recombinant TPR protein (His tag) Vector Maps pEnCMV-MMP12(human)-3xFLAG pEnCMV-Erbb2(mouse)-Myc-FLAG-SV40-Neo pEnCMV-OXT(human)-3xFLAG pLV3-CMV-SIX1(human)-3xFLAG-CopGFP-Puro pLV3-CMV-ST8SIA1(human)-3xFLAG-CopGFP-Puro pLV3-CMV-Man2a2(mouse)-3xFLAG-CopGFP-Puro pLV3-CMV-SLC22A10(human)-3xFLAG-CopGFP-Puro pEnCMV-Ufl1(mouse)-3xMyc pLV3-CMV-GAD1(human)-3xFLAG-CopGFP-Puro pcDNA3.1-Cav3(mouse)-3xFLAG Articles Cell: Secondary Metabolite Pathway Product BHB-Phe Can Suppress Appetite and Reduce Obesity The P1' specificity of tobacco etch virus protease RNA Splicing and Exon Trapping What are the differences between TetR and TcR
Research Applications (Reta Benefits) Reta is currently being investigated in a variety of non-clinical and preclinical models, particularly those related to metabolic health
